ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMM Immupharma Plc

2.42
0.17 (7.56%)
Last Updated: 16:04:17
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.17 7.56% 2.42 2.34 2.42 2.48 2.26 2.26 1,674,181 16:04:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -2.12 8.07M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.25p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £8.07 million. Immupharma has a price to earnings ratio (PE ratio) of -2.12.

Immupharma Share Discussion Threads

Showing 38751 to 38772 of 39125 messages
Chat Pages: Latest  1553  1552  1551  1550  1549  1548  1547  1546  1545  1544  1543  1542  Older
DateSubjectAuthorDiscuss
14/9/2022
11:33
It must be hard for shareholders to still trust Tim and have faith in him to deliver a return on investment
sclper
14/9/2022
11:29
You are welcome to them. Good luck!
arlington chetwynd talbott
14/9/2022
11:07
waterloo01 - 03 Aug 2022 - 17:14:41 - 38031 of 38311 IMMUPHARMA - IN FINAL PHASE 3 LUPUS TRIAL TARGETING BLOCKBUSTER ($1bn+) REVENUES - IMM

Nobby, if for any reason phase 3 doesn't run, the Lanstead death spiral will decimate them

waterloo01
14/9/2022
10:59
If they have a second generation tech being developed, in my view the best option would be, if they can get the funds, to learn lessons from this generation, to bin the old one, and to apply those lessons in the improved second gen tech. That said, I'm not holding and have no intention to without significant clarity as to the way forwards, partner commitments, funding, regulatory resolution etc. Far too much uncertainty and risk for this to be an investment, and as said above, still with a long way to potentially fall in the interim.
sicilian_kan
14/9/2022
10:57
They have been trying with the regulators to fix the P3 protocol now for over 2 years! It commenced with the (subsequently failed) SPA application announced on 27 July 2020. Then we had the PK issues, then this.
sicilian_kan
14/9/2022
10:52
Not really a surprise, though, is it? Nobby's been saying for years that it doesn't work at these dosing levels - that being the case, why would the FDA be less sceptical than he is?
supernumerary
14/9/2022
10:50
That's Tim for you. It's probably shorter to list what the FDA like than what they don't.
waterloo01
14/9/2022
10:49
I wouldn't be surprised if Avion dump the drug. After all they haven't actually spent much yet so could probably write it off relatively easily. I guess it depends how the contract is written....

I would love McCarthy to do another interview to explain himself!

nobbygnome
14/9/2022
10:48
That RNS feels like it skirts over the broad implications of this news, implications that could be stated right here and right now, whatever the detail of the way forward will look like. It feels a bit slimy and evasive, in other words.
arlington chetwynd talbott
14/9/2022
10:45
Lost £500 on a bad trade. Given my view of TM, I really should have resisted. Oh well. As for those buying.....market cap still £17m. It should probably be well into the low single figures, so another 50%+ downside to go.
waterloo01
14/9/2022
10:44
Did you all expect to multi-bag within a month?

I'm buying your shares on the cheap. Watch and learn.

david gruen
14/9/2022
10:43
As ever precise but vague - experts with a different view and unfortunately the FDA experts hold the key to approval; still if Avion experts thought investment worthwhile and PK study met the objective, whatever that was, then its unclear if the FDA response is a kiss of death or a delaying tactic. Strategical I think the company made a mistake in either:

- not selling rights to a large pharma
- seeking approval out of USA; US is toxic for example LUPUZOR was not US approved but was elsewhere in EU, Japan etc.

So jury is out, its ether still possible to fly or doomed, but as it came out of CNRS, another load of expert, maybe its still a fighting chance. So until we get, if ever, the real detail of FDA points its all foggy.

colsmith
14/9/2022
10:42
Another Tim but dim result.
waterloo01
14/9/2022
10:29
I've sold out of IMM on the news as well. Have a tonne of EVG which also in terms of share price has been disappointing.
manual dexterity
14/9/2022
10:20
Fortunately had none but that RNS is a clear sell in my view. Clarity needed to make any investment case at all.
sicilian_kan
14/9/2022
10:20
Thats not good. Ffs
neo26
14/9/2022
10:14
I'm out with a loss. McCarthy should be locked up....
nobbygnome
14/9/2022
10:12
This RNS should sink IMM share.

Very bad look

Sigh

eva_1989
14/9/2022
10:08
What a shocker. It looks like Tim did indeed lie…
nobbygnome
14/9/2022
09:42
Nobby - Thank you. Fingers crossed!

BS lord - it’s habit of Dogs to bark but I can’t stop them ;)

Hope I will show you the same screenshot for IMM

Enjoy

hxxps://paste.pics/0dced47fee45f15276e51bab32b43421

eva_1989
14/9/2022
09:01
Nobby - thought you might say that and I'm sure you also took other factors into account. But presumably Tim's previous predictions (which all turned out to be wrong) were also either written down or on camera?
lord loads of lolly
14/9/2022
08:43
And of course the 80:20 prediction does not only rely on that one statement…R30;
nobbygnome
Chat Pages: Latest  1553  1552  1551  1550  1549  1548  1547  1546  1545  1544  1543  1542  Older

Your Recent History

Delayed Upgrade Clock